Sun Life Finl (SLF) Market Value Rose While State Of Wisconsin Investment Board Has Cut Holding; Idexx Labs (IDXX) Holder Chicago Equity Partners Decreased Stake

May 22, 2018 - By Richard Conner

Sun Life Financial Inc. (NYSE:SLF) Logo

State Of Wisconsin Investment Board decreased its stake in Sun Life Finl Inc (SLF) by 1.83% based on its latest 2017Q4 regulatory filing with the SEC. State Of Wisconsin Investment Board sold 12,200 shares as the company’s stock rose 0.17% while stock markets declined. The institutional investor held 655,456 shares of the life insurance company at the end of 2017Q4, valued at $27.14M, down from 667,656 at the end of the previous reported quarter. State Of Wisconsin Investment Board who had been investing in Sun Life Finl Inc for a number of months, seems to be less bullish one the $26.60B market cap company. The stock increased 0.48% or $0.21 during the last trading session, reaching $43.78. About 80,940 shares traded. Sun Life Financial Inc. (NYSE:SLF) has risen 12.92% since May 22, 2017 and is uptrending. It has outperformed by 1.37% the S&P500.

Chicago Equity Partners Llc decreased its stake in Idexx Labs Inc (IDXX) by 18.94% based on its latest 2017Q4 regulatory filing with the SEC. Chicago Equity Partners Llc sold 23,513 shares as the company’s stock rose 21.09% while stock markets declined. The institutional investor held 100,614 shares of the health care company at the end of 2017Q4, valued at $15.73M, down from 124,127 at the end of the previous reported quarter. Chicago Equity Partners Llc who had been investing in Idexx Labs Inc for a number of months, seems to be less bullish one the $17.41B market cap company. The stock decreased 0.40% or $0.8 during the last trading session, reaching $200.39. About 39,206 shares traded. IDEXX Laboratories, Inc. (NASDAQ:IDXX) has risen 23.99% since May 22, 2017 and is uptrending. It has outperformed by 12.44% the S&P500.

State Of Wisconsin Investment Board, which manages about $36.44 billion US Long portfolio, upped its stake in General Mtrs Co (NYSE:GM) by 160,483 shares to 1.65 million shares, valued at $67.52M in 2017Q4, according to the filing. It also increased its holding in Liberty Media Corp Delaware by 148,823 shares in the quarter, for a total of 244,744 shares, and has risen its stake in Valeant Pharmaceuticals Intl (NYSE:VRX).

Analysts await Sun Life Financial Inc. (NYSE:SLF) to report earnings on August, 8. They expect $0.89 EPS, up 7.23% or $0.06 from last year’s $0.83 per share. SLF’s profit will be $540.77M for 12.30 P/E if the $0.89 EPS becomes a reality. After $1.00 actual EPS reported by Sun Life Financial Inc. for the previous quarter, Wall Street now forecasts -11.00% negative EPS growth.

Among 12 analysts covering Sun Life Financial Inc. (NYSE:SLF), 6 have Buy rating, 0 Sell and 6 Hold. Therefore 50% are positive. Sun Life Financial Inc. had 26 analyst reports since August 6, 2015 according to SRatingsIntel. On Thursday, September 10 the stock rating was upgraded by Macquarie Research to “Outperform”. Bank of America initiated the shares of SLF in report on Wednesday, August 24 with “Underperform” rating. On Friday, February 17 the stock rating was downgraded by RBC Capital Markets to “Sector Perform”. The stock of Sun Life Financial Inc. (NYSE:SLF) earned “Neutral” rating by Credit Suisse on Wednesday, May 10. Argus Research upgraded the stock to “Buy” rating in Wednesday, December 23 report. Morgan Stanley maintained Sun Life Financial Inc. (NYSE:SLF) rating on Thursday, October 5. Morgan Stanley has “Equal-Weight” rating and $53 target. IBC upgraded the shares of SLF in report on Thursday, February 11 to “Sector Outperform” rating. The rating was maintained by Morgan Stanley on Thursday, April 5 with “Equal-Weight”. Argus Research downgraded the shares of SLF in report on Friday, December 23 to “Hold” rating. On Friday, November 6 the stock rating was maintained by RBC Capital Markets with “Outperform”.

More notable recent Sun Life Financial Inc. (NYSE:SLF) news were published by: Fool.ca which released: “Manulife Financial Corp. Is Among Insurers That Will Rally in a Rising Interest Rate Environment” on May 10, 2018, also Prnewswire.com with their article: “Sun Life Financial hosts first quarter 2018 earnings conference call” published on April 25, 2018, Fool.ca published: “RRSP Investors: 2 Top Canadian Stocks to Play Global Growth” on May 15, 2018. More interesting news about Sun Life Financial Inc. (NYSE:SLF) were released by: Seekingalpha.com and their article: “Sun Life Financial, Inc. (SLF) CEO Dean Connor on Q1 2018 Results – Earnings Call Transcript” published on May 10, 2018 as well as Fool.ca‘s news article titled: “2 Canadian Stocks to Bet on Global Wealth Growth” with publication date: May 18, 2018.

More important recent IDEXX Laboratories, Inc. (NASDAQ:IDXX) news were published by: Fool.com which released: “IDEXX Laboratories Barks Out Another Successful Quarter” on May 11, 2018, also Seekingalpha.com published article titled: “Buy Diamondback Energy On Declines – Cramer’s Lightning Round (5/11/18)”, Fool.com published: “The 3 Stocks on the MFM Team’s Radar This Week” on May 10, 2018. More interesting news about IDEXX Laboratories, Inc. (NASDAQ:IDXX) was released by: Nasdaq.com and their article: “Research Report Identifies Cara Therapeutics, MGE Energy, IDEXX Laboratories, Sterling Construction, TTM …” with publication date: April 30, 2018.

Among 11 analysts covering IDEXX Laboratories (NASDAQ:IDXX), 7 have Buy rating, 2 Sell and 2 Hold. Therefore 64% are positive. IDEXX Laboratories had 29 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was maintained by Stifel Nicolaus with “Buy” on Monday, March 21. The stock has “Buy” rating by Bank of America on Wednesday, August 23. The rating was maintained by Stifel Nicolaus on Thursday, February 1 with “Buy”. Canaccord Genuity maintained IDEXX Laboratories, Inc. (NASDAQ:IDXX) on Monday, January 29 with “Buy” rating. Feltl & Co upgraded the stock to “Hold” rating in Friday, July 24 report. The rating was maintained by Canaccord Genuity on Monday, August 21 with “Buy”. Canaccord Genuity maintained it with “Buy” rating and $98 target in Wednesday, July 20 report. Stifel Nicolaus maintained IDEXX Laboratories, Inc. (NASDAQ:IDXX) on Thursday, August 13 with “Buy” rating. As per Friday, February 2, the company rating was maintained by Bank of America. As per Tuesday, June 13, the company rating was maintained by Canaccord Genuity.

Analysts await IDEXX Laboratories, Inc. (NASDAQ:IDXX) to report earnings on August, 7. They expect $1.18 EPS, up 24.21% or $0.23 from last year’s $0.95 per share. IDXX’s profit will be $102.50 million for 42.46 P/E if the $1.18 EPS becomes a reality. After $1.01 actual EPS reported by IDEXX Laboratories, Inc. for the previous quarter, Wall Street now forecasts 16.83% EPS growth.

Since January 9, 2018, it had 2 insider purchases, and 7 sales for $23.44 million activity. END WILLIAM T had sold 9,470 shares worth $1.97 million on Thursday, May 10. Kingsley Lawrence D also bought $178,045 worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX) shares. 2,974 IDEXX Laboratories, Inc. (NASDAQ:IDXX) shares with value of $565,232 were sold by JUNIUS DANIEL M. On Monday, February 5 the insider MCKEON BRIAN P sold $1.20 million. On Wednesday, February 7 the insider Claflin Bruce L. bought $179,580.

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>